| biologic disease modifying anti-rheumatic drugs |
271 |
| rheumatoid arthritis |
271 |
| synthetic disease modifying anti-rheumatic drugs |
271 |
| treatment recommendations |
271 |
| low birth weight and length |
285 |
| maternal and neonatal deaths |
285 |
| pregnancy |
285 |
| systemic lupus erythematosus |
285, 353 |
| balneotherapy |
292 |
| functional outcome |
292 |
| knee osteoarthritis |
292 |
| physical therapy |
292 |
| mechanical neck pain |
298 |
| mud therapy |
298 |
| spa therapy |
298 |
| carotid intima-media thickness |
307 |
| fibromyalgia |
307, 334 |
| ultrasound |
307 |
| cardiopulmonary complications |
311 |
| disease activity |
311 |
| scleroderma |
311 |
| behçet’s disease |
319 |
| human leukocyte antigen-b51 |
319 |
| smoking |
319 |
| ankylosing spondylitis |
326, 349 |
| obstructive sleep apnea syndrome |
326 |
| polysomnography |
326 |
| sleep efficiency |
326 |
| interleukin 1beta |
334 |
| interleukin 6 |
334 |
| interleukin 8 |
334 |
| tumor necrosis factor α |
334 |
| cardiac repolarization |
343 |
| familial mediterranean fever |
343 |
| jt dispersion |
343 |
| qt dispersion |
343 |
| acute lymphoid leukemia |
349 |
| anti-tumor necrosis factor-alpha drugs |
349 |
| magnetic resonance imaging |
353 |
| sjögren’s syndrome |
353 |
| dupuytren's contracture |
357 |
| treatment |
357 |
| ultrasound elastography |
357 |
| cyclophosphamide |
361 |
| glucocorticoid |
361 |
| methotrexate |
361 |
| neuropsychiatric systemic lupus erythematosus |
361 |
| parkinsonism |
361 |
